Charles River Laboratories International, Inc. (CRL) Valuation
Historical valuation analysis based on 500 data points (2024-08-30 to 2026-08-28)
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of anima...
Charles River Laboratories International, Inc. (CRL) currently trades at a P/E ratio of 18.95 (historical range: 18.52–26.93, median: 22.64), placing it at the 3th percentile — cheap relative to its history, P/S ratio of 3.57 (range: 1.26–3.66, 99th percentile — expensive relative to its history), EV/EBITDA of 140.67 (range: 28.74–523.10, 86th percentile).
Charles River Laboratories International, Inc. appears slightly overvalued relative to its historical range, with most valuation metrics above their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 18.95 | 18.52 | 22.64 | 26.93 | 3th | cheap relative to its history |
| P/S Ratio | 3.57 | 1.26 | 2.17 | 3.66 | 99th | expensive relative to its history |
| EV/EBITDA | 140.67 | 28.74 | 58.81 | 523.10 | 86th | expensive relative to its history |
| FCF Yield | 0.07 | 0.01 | 0.04 | 0.07 | 97th | cheap relative to its history |